garenoxacin has been researched along with Sinusitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, M; Ito, M; Kondo, S; Maruyama, Y; Miwa, T; Murono, S; Nakanishi, S; Wakisaka, N; Yoshizaki, T | 1 |
| Ambrose, PG; Bello, A; Costanzo, C; Echols, R; Gajjar, DA; Grasela, DM; Grasela, TH; Ludwig, EA; Phillips, L; Russo, R; Van Wart, S | 1 |
1 trial(s) available for garenoxacin and Sinusitis
| Article | Year |
|---|---|
Efficacy and safety of garenoxacin in the treatment of upper respiratory tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Laryngitis; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Treatment Outcome | 2012 |
1 other study(ies) available for garenoxacin and Sinusitis
| Article | Year |
|---|---|
Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bronchitis; Community-Acquired Infections; Drug Interactions; Female; Fluoroquinolones; Food-Drug Interactions; Humans; Male; Mass Spectrometry; Middle Aged; Models, Biological; Pneumonia; Population; Reproducibility of Results; Respiratory Tract Infections; Sinusitis | 2004 |